| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ADVANCES IN NURSING SCIENCE LetPub Score 5.2
50 ratings
Rate
Reputation 6.3 Influence 3.6 Speed 8.8 | ||||||||||||||||
| 期刊簡稱 | ADV NURS SCI | ||||||||||||||||
| ISSN | 0161-9268 | ||||||||||||||||
| E-ISSN | 1550-5014 | ||||||||||||||||
| h-index | 54 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | http://journals.lww.com/advancesinnursingscience/pages/default.aspx | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/ANS | ||||||||||||||||
| 開放訪問 | No | ||||||||||||||||
| 出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||
| 發行頻率 | 四半期刊行 | ||||||||||||||||
| 創刊年 | 1978 | ||||||||||||||||
| 每年文章數 | 43每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 4.24% | ||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded Social Science Citation Index | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0161-9268%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [ADVANCES IN NURSING SCIENCE] 的評論 | 撰寫評論 |
| 作者: 稻妻智伟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2022-06-07 12:37:04 評論於 Hello, may I ask if this magazine has high requirements?  (0) 讚！ | 稻妻智伟  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 18:36:56 評論於 It is still necessary for us to clearly explain the limitations of the research in the paper and to specify how these limitations affect the conclusions of the paper, so that reviewers and other readers can understand that we have thoroughly considered the limitations of the study. Typically, discussing the limitations of the research work in the discussion section of the paper enhances the credibility of the article. Thinking about how to overcome these limitations in future research will have a positive impact (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 15:08:59 評論於 We suggest dividing the discussion of research limitations into three parts: (1) identifying research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement suggestions. Discussing research limitations in this order can help you clearly identify research deficiencies without compromising the quality and validity of the research (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 22:32:09 評論於 Do we need to explain the limitations of the article in the discussion? (0) 讚！ | 修然小公主 |
| 作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 21:39:41 評論於 How to write about limitations in a discussion? (0) 讚！ | Oswald Edie |
| 作者: Carter 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-28 17:38:42 評論於 This journal publishes articles that are relatively general. I personally know two of the reviewers, and they are both very fast. (0) 讚！ | Carter |
| 作者: 明冠岚翠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-09-27 13:24:18 評論於 Review speed: 1.0 | Submission success rate: 25.0 Experience sharing: The quality of the articles is average, but it's still worth submitting. I got two articles accepted and the review process was very fast (0) 讚！ | 明冠岚翠 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
